缩写名/全名 |
ONCOLOGIST
ONCOLOGIST |
||||||||||||||||||||
ISSN号 | 1083-7159 | ||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
影响因子 | 2015:4.789, 2016:4.962, 2017:5.306, 2018:5.252, 2019:5.025, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 207 | ||||||||||||||||||||
出版年份 | 1996 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 一般,3-8周 |
||||||||||||||||||||
录用比例 | 较难 | ||||||||||||||||||||
投稿链接 | https://manuscriptsubmissions.theoncologist.com/ | ||||||||||||||||||||
投稿官网 | http://theoncologist.alphamedpress.org/ | ||||||||||||||||||||
h-index | 145 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1083-7159%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
中国学者近期发表的论文 | |
1. | A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer. Author: Chen X1, Qiu T1, Zhu Y2, Sun J1, Li P1, Wang B1, Lin P3, Cai X1, Han X1, Zhao F1, Shu Y1, Chang L4, Jiang H5, Gu Y6. Journal: Oncologist. 2019 Mar 15. pii: theoncologist.2019-0164. doi: 10.1634/theoncologist.2019-0164. [Epub ahead of print] PubMed DOI |
2. | Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer. Author: Wen S1, Dai L2, Wang L1, Wang W3, Wu D3, Wang K3, He Z4, Wang A5, Chen H5, Zhang P5, Dong X5, Dong YA5, Wang K5,6, Yao M5, Wang M7. Journal: Oncologist. 2019 Mar 22. pii: theoncologist.2018-0572. doi: 10.1634/theoncologist.2018-0572. [Epub ahead of print] PubMed DOI |
3. | Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial. Author: Zhou AP1, Bai Y2, Song Y1, Luo H3, Ren XB4, Wang X5, Shi B5, Fu C6, Cheng Y7, Liu J8, Qin S9, Li J10, Li H11, Bai X12, Ye D13, Wang J1, Ma J14. Journal: Oncologist. 2019 Mar 22. pii: theoncologist.2018-0839. doi: 10.1634/theoncologist.2018-0839. [Epub ahead of print] PubMed DOI |
4. | Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy. Author: Lin JX1,2,3, Lin JP1,2, Xie JW1,2,3, Wang JB1,2,3, Lu J1,2, Chen QY1,2, Cao LL1,2, Lin M1,2, Tu R1,2, Zheng CH4,2,3, Huang CM4,2,3, Li P4,2,3. Journal: Oncologist. 2019 Mar 25. pii: theoncologist.2018-0651. doi: 10.1634/theoncologist.2018-0651. [Epub ahead of print] PubMed DOI |
5. | Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis. Author: Gong ZJ1,2, Cheng JW1, Gao PT1, Huang A1, Sun YF1, Zhou KQ1, Hu B1, Qiu SJ1, Zhou J1,3, Fan J1,3, Yang XR4. Journal: Oncologist. 2019 Mar 25. pii: theoncologist.2018-0268. doi: 10.1634/theoncologist.2018-0268. [Epub ahead of print] PubMed DOI |
6. | Clinical and Prognostic Characteristics of 53 Cases of Extracranial Malignant Rhabdoid Tumor in Children. A Single-Institute Experience from 2007 to 2017. Author: Cheng H1, Yang S1, Cai S2, Ma X3, Qin H1, Zhang W4, Fu L5, Zeng Q6, Wen M7,8, Peng X2, Wang H9. Journal: Oncologist. 2019 Mar 26. pii: theoncologist.2018-0416. doi: 10.1634/theoncologist.2018-0416. [Epub ahead of print] PubMed DOI |
7. | Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule. Author: Yang X1,2,3, Dong X1,2, Wang J4, Li W4, Gu Z4, Gao D4, Zhong N5, Guan Y6,2. Journal: Oncologist. 2019 Apr 1. pii: theoncologist.2018-0706. doi: 10.1634/theoncologist.2018-0706. [Epub ahead of print] PubMed DOI |
8. | Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type. Author: Lin N1, Ku W2, Song Y1, Zhu J3, Lu Z4. Journal: Oncologist. 2019 Apr 2. pii: theoncologist.2017-0588. doi: 10.1634/theoncologist.2017-0588. [Epub ahead of print] PubMed DOI |
9. | Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma. Author: Feng X1, Li L1, Wu J1, Zhang L1, Sun Z1, Li X1, Wang X1, Yu H1, Chang Y1, Wu X1, Zhou Z1, Wang G2, Li W2, Li Z1, Zhang X1, Zhang M3. Journal: Oncologist. 2019 Apr 5. pii: theoncologist.2018-0789. doi: 10.1634/theoncologist.2018-0789. [Epub ahead of print] PubMed DOI |
10. | Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Author: Han Y1, Yang J1, Liu P1, He X1, Zhang C1, Zhou S1, Zhou L1, Qin Y1, Song Y2, Sun Y1, Shi Y3. Journal: Oncologist. 2019 Apr 5. pii: theoncologist.2018-0361. doi: 10.1634/theoncologist.2018-0361. [Epub ahead of print] PubMed DOI |
|
|